Purpose: Several studies have reported the prevalence and incidence of febrile seizure (FS) among children in the USA and other countries. However, recent trends in FS among hospitalized children, hospital course, and risk factors for its severity remain unknown at a national level in the USA. Method: Hospital discharge records of patients with FS aged <6 years were obtained for the years 2003, 2006, 2009, and 2012 from the Kid's Inpatient Database. Data were weighted to estimate the annual hospitalization rates with respect to gender and race/ethnicity in the United States. Multivariable logistic regression was conducted to ascertain factors associated with FS severity. Results: A decreasing trend in total annual hospitalization rates due to FS was observed, ranging from 59.0 per 100,000 children in 2003 to 40.8 per 100,000 children in 2012 (p < 0.001). Winter predominance of hospitalizations was observed (p = 0.001). Hispanic children and children admitted to hospitals in northeast region were less likely to be severely affected. Age, gender, health insurance status, and household income level were not associated with FS severity. Conclusions: Total hospitalization rates due FS is decreasing, and race/ethnicity and geographic locations of the patients were associated with FS severity.
Introduction
Febrile seizure (FS), the most frequent seizure observed in children, is characterized by episodes of convulsions that occur in association with fever in children aged less than 6 years in the absence of a central nervous system (CNS) infection or an electrolyte imbalance [1] [2] [3] [4] [5] . FS is believed to be a benign seizure syndrome distinct from other neurologic disorders [4] .
Several studies have investigated the epidemiology of FS, including its prevalence, and gender-, age-, and race/ethnicityspecific variations. The incidence of FS peaks at the age of 18 months, and is 2%-9% among all children [1] [2] [3] [4] [5] . The incidence is the highest among children living in Asian and Pacific Island countries, and is higher in boys than girls, with a male-to-female ratio of 1.1-2.0 [2] [3] [4] [5] [6] [7] [8] . In addition, seasonal variation has been reported in Finland, Japan, and the USA, and the highest incidence observed in winter, and the lowest in summer [7, 8] . However, the USA's national data remain unclear regarding the epidemiology and hospital course of inpatients with FS.
To address these gaps in knowledge, the present study was conducted to investigate annual hospitalization rates due to FS and identify its epidemiological characteristics (differences in gender, race/ethnicity, geographic locations, and seasonal variations) in the entire USA. We also determined the mean cost of hospitalization and mean length of hospital stay, stratified by year of admission, and ascertained factors that were associated with FS severity.
Methods

Study population and participation
We analyzed data of hospital discharge records about patients aged 6 years or younger with FS for the years 2003, 2006, 2009 , and 2012 using the US representative Kids Inpatient Database (KID). The Agency for Healthcare Research and Quality (AHRQ) compiled the data, and the Healthcare Cost and Utilization Project (HCUP) generated the database in collaboration with public and private statewide data organizations [9, 10] . The KID is a large national all-payer hospital pediatric discharge database. The KID is designed to generate robust national estimates of annual pediatric hospitalizations, and is aimed to present hospital use, outcome, and healthcare cost [9, 10] . The KID sampling frame was constructed based on all US short-term, non-federal, general, and specialty hospitals participating in the HCUP [9, 10] . The KID had approximately 3 million pediatric discharges in each sample from 36 states  in 2003, 38 states in 2006, and 44 states in 2009 and 2012 [11] [12] [13] [14] . Discharge weight (DISCWT) variables were provided with the KID to obtain the national estimates of hospitalizations in the United States [9, 10] .
Hospitalizations with FS were identified using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9CM) code (780.31: febrile convulsions (simple), unspecified, and 780.32: complex febrile convulsions) in the primary or secondary diagnosis fields, and they were weighted with DISCWT variables to calculate the estimated number of hospitalizations in the entire United States.
Measurements of variables
Patient characteristics included age, gender (male or female), and race/ethnicity (black, Hispanic, white, Asian or Pacific Islanders, others (Native American and other types), and unknown). Patient socioeconomic status consisted of primary payer information (private, Medicare/Medicaid, other types (self-pay, no insurance, or no information)), and median household income quartiles for counties of residence (see Supplement 1) . We excluded patients with chronic medical conditions (congenital heart, kidney, pulmonary, endocrine, hematologic, gastrointestinal, and neurologic diseases; cancer or leukemia; and autoimmune disease) using pediatric complex chronic conditions classification system version 2 [15] .
Hospital characteristics included hospital regions (Northeast, Midwest, South, or West), hospital types (urban teaching, urban nonteaching, or rural), and hospital sizes (small, medium, or large). The definitions of hospital sizes are different across the location of the hospital (Supplement 2).
Outcomes
The outcomes of interest were FS-associated annual hospitalization rates with respect to gender and race/ethnicity. Annual FSassociated hospitalization rates were calculated; the number of hospitalizations as the numerator and the corresponding population of each subgroup as the denominator according to the US census in 2003, 2006, 2009 and 2012 [16-20] . The number of hospitalizations by months was also obtained during [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] . Total costs were calculated from total hospitalization charges using cost-to-charge ratio according to the HCUP recommendations [9] [10] [11] [12] [13] [14] .
Severity of illness was captured from the hospitalization's All Patient Refined-Drug-related Groups (APR-DRG) code [9] [10] [11] [12] [13] [14] . The system of DRG was developed and used for Medicare as a prospective payment system to classify hospital cases into 1 of approximately 500 groups to have similar hospital resource use. APR-DRG is a refinement of the system, and it accounts for severity of illness and risk of mortality. Severity of illness in APR-DRG was categorized into four groups (minor, medium, major or extreme), and it was determined by combinations of clinical information, including patient characteristics, primary diagnosis, comorbidity, and procedures that the patients received. We defined major-toextreme severity of illness defined by APR-DRG as severe, and mild-to-medium severity of illness as non-severe, and ascertained factors (age, gender, race/ethnicity, socioeconomic status and geographic location) associated with severity, after adjusting for patient and hospital characteristics, and years of admissions.
Statistical analysis
Descriptive statistics, including continuous and categorical data, were summarized. The number of FS-related hospitalizations and the proportions of hospitalizations by month were calculated using DISCWT. We determined annual hospitalization rates with respect to gender and race/ethnicity, and calculated 95% confidence interval, assuming a normal approximation to a Poisson distribution. We used chi-square test for linear-trend analyses of annual hospitalization rates between 2003 and 2012. Two-way analysis of variance (ANOVA) was performed to check the seasonal variations.
To investigate the secular trends for healthcare cost and length of hospital stay in days from the years 2003 to 2012, we constructed multivariable linear regression model adjusting for patient and hospital characteristics with the reference year of 2003. Multivariable logistic regression with dichotomous outcome (severe or non-severe) was conducted to investigate the factors associated with severity. The results were adjusted for patient and hospital characteristics as well as years of admissions, and were reported with 95% confidence intervals. Statistical significance was two-sided p < 0.05 for all tests. All data were analyzed using STATA software version 14.1 (StataCorp LP, Texas, USA).
Results
We identified a total of 16,337 patient discharges in 2003, 13,986 discharges in 2006, 13,169 discharges in 2009, and 11,505 discharges in 2012 among children aged 6 years or younger with FS in the USA. Table 1 described the characteristics of age, gender, race/ethnicity, socioeconomic status, and hospital characteristics among children hospitalized children FS. The mean age and maleto-female ratios did not change over the study period. The proportions of children with unknown race/ethnicity decreased from 22.4% in 2003 to 7.0% in 2012. More than 90% of children were covered by private insurance or Medicare/Medicaid. Patients with very-low or low median income levels were more likely to be hospitalized with FS. The majority of patients with FS were hospitalized in urban teaching hospital (54.3%-68.4%) with large bed size (54.0%-66.0%). Mean length of hospital stays in days significantly changed from 2.26 days in 2003 to 2.01 days in 2012 (P trend < 0.001). The mean health care costs for hospitalizations significantly increased from 2870 USD in 2003 to 3792 USD in 2012 (P trend < 0.001).
The annual FS-associated hospitalization rates with respect to gender and race/ethnicity were summarized in Table 2 . The total annual hospitalization rates showed a decreasing trend, ranging from 59.0 per 100,000 children in 2003 to 40.8 per 100,000 children in 2012 (p < 0.001). The annual hospitalization rates in boys were consistently greater than those in girls with male-tofemale ratio of 1.14-1.22. Significant downward linear-trends of the annual rates were observed among black children, ranging from 59.2 per 100,000 children in 2003 to 51.4 per 100,000 children in 2012 (p < 0.001), and among Hispanic children, ranging from 69.9 per 100,000 children in 2003 to 44.8 per 100,000 children in 2012 (p < 0.001). The hospitalization rates among white children and children of Asian or Pacific Island ancestry did not show upward or downward linear-trends over the period. Fig. 1 showed the proportions of FS-associated hospitalizations by months and years. The winter seasonality predominance was observed (p = 0.001). We conducted a sensitivity analysis among hospitalized patients with FS in December stratified by year of admission to investigate the higher proportions of hospitalizations Multivariable logistic regression was conducted to ascertain the factors (age categories, race/ethnicity, socioeconomic status and geographic locations) that were associated with severe conditions at admissions, after adjusting for hospital characteristics, seasonality as well as years of admissions. Age, gender, primary payer information, and median household income were not significantly associated with FS severity. Hispanic children hospitalized with FS had lower odds of being severely affected than white children did (Odds Ratio (OR), 0.69; 95%CI, 0.72-1.01; p-value, <0.001). Children admitted to the hospitals located in northeast had significantly lower odds of being severely affected than those admitted to the hospitals located in Midwest, South, or West did (p < 0.001) ( Table 4 ).
Discussion
The present study demonstrates the most recent national trends in hospitalized children with FS in the USA for the years a "Others" consists of Native American and other types of race/ethnicity. b "Unknown" is the missing data. c "LOS" is length of hospital stay (day).
2003-2012. The total annual hospitalization rates due to FS followed a linear downward trend. The annual hospitalization rates among Black and Hispanic children also showed decreasing trends. Winter-predominance was observed, and the proportion of influenza virus infections was significantly higher in December 2003 than in other admission years. We also investigated factors associated with FS severity. Race/ethnicity and hospital locations were significantly associated with FS severity. Several epidemiological studies have described the prevalence of FS [7, 8, 21, 22] . In Europe and the USA, 2%-4% of all children experience at least one episode of FS before the age of 5 years [22] . The cumulative incidence of FS is high in Asia and the Pacific Islands, but differences exist between China (1%), Japan (8.8%), India (10%), and Guam (14%) [22] . Thus, race/ethnicity and geographic location seem to be important factors in the development of FS, suggesting a possible genetic predisposition. However, there are no data regarding hospitalization rates with respect to race/ethnicity in the USA. We showed that Black and Hispanic children are overrepresented among hospitalized children with FS.
We observed that the total annual hospitalization rates decreased from 59.0 per 100,000 children in 2003 to 40.8 per 100,000 in 2012. The mean length of hospital stays also reduced from 2.26 days in 2003 to 2.01 days in 2012. We believe that several factors explain these decreasing trends. Introduction of tridecavalent pneumococcal capsular polysaccharide vaccines of pneumococcus and Hib vaccines have decreased an incidence of bacterial meningitis that led to changes in treatment guideline for simple and complex FS in the USA [23, 24] . Changes in recommendations of clinical practices, especially regarding lumbar puncture, may have altered managements and hospitalization rates for patients with FS [23, 24] . Recent increase in boardcertified pediatric emergency provider may also have contributed to these trends.
Seasonal variations in the incidence of FS were observed in Finland, Japan, and the USA [7, 8, 25] . Similar to previous findings, our results support the winter predominance, indicating the association with different causative infectious agents according to the seasons. In a previous study between October 2003 and September 2004, infections with influenza virus type A were associated with prolonged postictal impairment of consciousness in Japan [26] . Our study showed that the number of FS hospitalizations and the proportion of influenza infections among hospitalized children with FS in December 2003 were significantly higher than those in other years. Our finding of a high incidence of FS in December 2003 can be explained by the possible association between influenza infection and development of FS in children, as the effectiveness of influenza vaccines for the 2003/2004 was reported to be very low (3%-14%) [27] . These results suggest that effectiveness of influenza vaccinations and pandemic of influenza infections may have modified the annual hospitalization rates of FS over the period. Further studies are required to explore the associations between effectiveness of influenza vaccination, types of influenza infections, and development and illness severity of FS.
Our results demonstrate that children with very-low household income levels were more likely to be hospitalized. This relationship between low socioeconomic status and hospitalization due to FS may reflect parental anxiety and family dysfunction in families of low socioeconomic status, as indicated by a previous study [28] . The impacts of age, gender, race/ethnicity, patient socioeconomic status, and geographic location on FS severity have been unknown in the US. Our results demonstrated that patient age, gender, and socioeconomic status (including health insurance status and median household income levels), were not risk factors for FS severity. Children with FS who were Hispanic or hospitalized in the northeast region of the USA were less likely to be severely affected than those hospitalized in other regions. We speculate that the underlying reasons for this disparity are multifactorial, such as differences in admission criteria for FS, access to healthcare, and causative infectious agents by geographic location. However, we cannot directly identify these factors because of the constraints of the database. Further investigations are warranted to obtain a better understanding of these factors. There are several limitations to our study. The number of FSassociated hospitalization and their rates may have been underestimated because of possible miscoding or misclassification. The detailed clinical presentation, physical examination, laboratory data, and results of the imaging studies were unavailable in the KID. KID captures only children hospitalized with FS at a national level; therefore, we cannot identify the prevalence and incidence of FS in the entire USA, including children who were not hospitalized. Patients may be hospitalized several times; however we could not identify the recurrence and readmission rates of FS due to the lack of unique patient identifiers in the KID. In addition, even though APR-DRG code is refined methodology to classify patient illness severity and it is applicable across patients with the same primary diagnosis, the validity of illness severity defined by APR-DRG code was uncertain compared with data with detailed clinical information including patient physical examination, laboratory data, and results of imaging studies.
A unique feature and strength of this study was the use of KID, which is the only national pediatric inpatient database currently available in the US so that our analyses reflected overall US pediatric population, whereas other database, such as Pediatric Health Information System or Medicaid database, can capture pnlu a limited portion of the populations, such as those hospitalized in children's hospitals or those covered by Medicaid. Using KID, we were able to calculate robust national estimates of epidemiology of children hospitalized with FS in the entire US.
Conclusion
In summary, we provided novel insights into the current epidemiology of hospitalized children with FS and risk factors associated with its severity. We believe that our investigations could provide valuable and useful information for further etiological or epidemiological studies of FS in order to investigate the potential risk factors for the development and severity of FS and explain the seasonal and geographic variations. 
